BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 33011896)

  • 1. Thromboelastography findings in critically ill COVID-19 patients.
    Salem N; Atallah B; El Nekidy WS; Sadik ZG; Park WM; Mallat J
    J Thromb Thrombolysis; 2021 May; 51(4):961-965. PubMed ID: 33011896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
    Maatman TK; Jalali F; Feizpour C; Douglas A; McGuire SP; Kinnaman G; Hartwell JL; Maatman BT; Kreutz RP; Kapoor R; Rahman O; Zyromski NJ; Meagher AD
    Crit Care Med; 2020 Sep; 48(9):e783-e790. PubMed ID: 32459672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019.
    Yuriditsky E; Horowitz JM; Merchan C; Ahuja T; Brosnahan SB; McVoy L; Berger JS
    Crit Care Med; 2020 Sep; 48(9):1319-1326. PubMed ID: 32618696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time.
    Park MS; Martini WZ; Dubick MA; Salinas J; Butenas S; Kheirabadi BS; Pusateri AE; Vos JA; Guymon CH; Wolf SE; Mann KG; Holcomb JB
    J Trauma; 2009 Aug; 67(2):266-75; discussion 275-6. PubMed ID: 19667878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19.
    Kartiko S; Koizumi N; Yamane D; Sarani B; Siddique AB; Levine AR; Jackson AM; Wieruszewski PM; Smischney NJ; Khanna AK; Chow JH;
    J Intensive Care Med; 2023 May; 38(5):449-456. PubMed ID: 36448250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series.
    Wang J; Hajizadeh N; Shore-Lesserson L
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2536-2543. PubMed ID: 34802831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of central venous catheters induces a hypercoagulable state.
    Ryan ML; Thorson CM; King DR; Van Haren RM; Manning RJ; Andrews DM; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2012 Aug; 73(2):385-90. PubMed ID: 22846944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():145-147. PubMed ID: 32291094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.
    Shah A; Donovan K; McHugh A; Pandey M; Aaron L; Bradbury CA; Stanworth SJ; Alikhan R; Von Kier S; Maher K; Curry N; Shapiro S; Rowland MJ; Thomas M; Mason R; Holland M; Holmes T; Ware M; Gurney S; McKechnie SR
    Crit Care; 2020 Sep; 24(1):561. PubMed ID: 32948243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.
    Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
    Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
    Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
    Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis.
    Mestre-Gómez B; Lorente-Ramos RM; Rogado J; Franco-Moreno A; Obispo B; Salazar-Chiriboga D; Saez-Vaquero T; Torres-Macho J; Abad-Motos A; Cortina-Camarero C; Such-Diaz A; Ruiz-Velasco E; Churruca-Sarasqueta J; Muñoz-Rivas N;
    J Thromb Thrombolysis; 2021 Jan; 51(1):40-46. PubMed ID: 32613385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers D; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
    Thromb Res; 2020 Jul; 191():148-150. PubMed ID: 32381264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study.
    Pellegrini JAS; Rech TH; Schwarz P; de Oliveira ACT; Vieceli T; Moraes RB; Sekine L; Viana MV
    J Thromb Thrombolysis; 2021 Aug; 52(2):482-492. PubMed ID: 33599858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
    Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Thromboelastography and velocity curve derivative in diagnosing COVID-19 associated coagulopathy.
    Mohan G; Wilson W; Paonam B; Vaidya A; Ravindra P; Shastry S; Balakrishnan JM; Rao S; Chaudhuri S
    Int J Lab Hematol; 2022 Oct; 44(5):823-830. PubMed ID: 35609623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.